Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R.E.C.K vs Exparel in Robotic Nephrectomy
NCT07092566Phase 3Recruiting
- Sponsor
- Wake Forest University Health Sciences
- Start
- Nov 2025
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupivacaine extended release liposome injection in pain, sponsored by Wake Forest University Health Sciences. Started Nov 2025; status: recruiting.
02
Drugs
bupivacaine extended release liposome injection
03
Conditions
pain
Beyond the preview
Go deeper on NCT07092566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07092566.